TL1A both promotes and protects from renal inflammation and injury

Journal of the American Society of Nephrology

Volumn 19, Issue 5, 2008, Pages 953-960

  Al Lamki, Rafia S ^a,g   Wang, Jun ^a   Tolkovsky, Aviva M ^c   Bradley, J Andrew ^b   Griffin, Jules L ^c   Thiru, Sathia ^c   Wang, Eddie C Y ^f   Bolton, Eleanor ^b   Min, Wang ^d   Moore, Paul ^e   Pober, Jordan S ^d   Bradley, John R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e GLAXOSMITHKLINE   (United States)

^f CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^g ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DEATH RECEPTOR 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; VASCULOTROPIN; MESSENGER RNA; TNFRSF25 PROTEIN, HUMAN; TNFRSF25 PROTEIN, MOUSE; TNFSF15 PROTEIN, HUMAN; TNFSF15 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY INJURY; LEUKOCYTE; MOUSE; NEPHRECTOMY; NEPHRITIS; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RENAL PROTECTION; VASCULAR ENDOTHELIUM; ANIMAL; BIOPSY; C57BL MOUSE; GENETICS; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; METABOLISM; MOUSE MUTANT; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; BIOPSY; CASPASE 3; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NEPHRITIS; NF-KAPPA B; ORGAN CULTURE TECHNIQUES; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RNA, MESSENGER; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 44049085188     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007060706     Document Type: Article

References (24)

1. Marsters SA, Sheridan JP, Donahue CJ, Pitti RM, Gray CL, Goddard AD, Bauer KD, Ashkenazi A: Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B. Curr Biol 6: 1669-1676, 1996
2. Ashkenazi A: Targeting death and decoy receptors of the tumournecrosis factor superfamily. Nat Rev Cancer 2: 420-430, 2002
3. Bhardwaj A, Aggarwal BB: Receptor-mediated choreography of life and death. J Clin Immunol 23: 317-332, 2003
4. Chinnaiyan AM, O'Rourke K, Yu GL, Lyons RH, Garg M, Duan DR, Xing L, Gentz R, Ni J, Dixit VM: Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274: 990-992, 1996
5. Al-Lamki RS, Wang J, Thiru S, Pritchard NR, Bradley JA, Pober JS, Bradley JR: Expression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplants. Am J Pathol 163: 401-411, 2003
6. Kitson J, Raven T, Jiang YP, Goeddel DV, Giles KM, Pun KT, Grinham CJ, Brown R, Farrow SN: A death-domain-containing receptor that mediates apoptosis. Nature 384: 372-375, 1996
7. Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, Bornand T, Hahne M, Schroter M, Becker K, Wilson A, French LE, Browning JL, MacDonald HR, Tschopp J: TRAMP, a novel apoptosismediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6: 79-88, 1997
8. Migone TS, Zhang J, Luo X, Zhuang L, Chen C, Hu B, Hong JS, Perry JW, Chen SF, Zhou JX, Cho YH, Ullrich S, Kanakaraj P, Carrell J, Boyd E, Olsen HS, Hu G, Pukac L, Liu D, Ni J, Kim S, Gentz R, Feng P, Moore PA, Ruben SM, Wei P: TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16: 479-492, 2002
9. Bamias G, Martin C III, Marini M, Hoang S, Mishina M, Ross WG, Sachedina MA, Friel CM, Mize J, Bickston SJ, Pizarro TT, Wei P, Cominelli F: Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol 171: 4868-4874, 2003
10. Prehn JL, Mehdizadeh S, Landers CJ, Luo X, Cha SC, Wei P, Targan SR: Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation. Clin Immunol 112: 66-77, 2004
11. Al-Lamki RS, Wang J, Vandenabeele P, Bradley JA, Thiru S, Luo D, Min W, Pober JS, Bradley JR: TNFR1-and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury. FASEB J 19: 1637-1645, 2005
12. Kim S, Zhang L: Identification of naturally secreted soluble form of TL1A, a TNF-like cytokine. J Immunol Methods 298: 1-8, 2005
13. Liu SF, Ye X, Malik AB: Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes. Circulation 100: 1330-1337, 1999
14. Aerbajinai W, Zhu J, Gao Z, Chin K, Rodgers GP: Thalidomide induces gamma-globin gene expression through increased reactive oxygen species-mediated p38 MAPK signaling and histone H4 acetylation in adult erythropoiesis. Blood 110: 2864-2971, 2007
15. Wang EC, Thern A, Denzel A, Kitson J, Farrow SN, Owen MJ: DR3 regulates negative selection during thymocyte development. Mol Cell Biol 21: 3451-3461, 2001
16. AI-Lamki RS, Wang J, Skepper JN, Thiru S, Pober JS, Bradley JR: Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Invest 81: 1503-1515, 2001
17. Marconi A, Atzei P, Panza C, Fila C, Tiberio R, Truzzi F, Wachter T, Leverkus M, Pincelli C: FLICE/caspase-8 activation triggers anoikis induced by beta1-integrin blockade in human keratinocytes. J Cell Sci 117: 5815-5823, 2004
18. Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K, Liu YC, Karin M: The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 124: 601-613, 2006
19. Li Y, Dai C, Wu C, Liu Y: PINCH-1 promotes tubular epithelial-to- mesenchymal transition by interacting with integrin-linked kinase. J Am Soc Nephrol 18: 2534-2543, 2007
20. Li Y, Yang J, Luo JH, Dedhar S, Liu Y: Tubular epithelial cell dedifferentiation is driven by the helix-loop-helix transcriptional inhibitor ld1. J Am Soc Nephrol 18: 449-460, 2007
21. Bamias G, Mishina M, Nyce M, Ross WG, Kollias G, Rivera-Nieves J, Pizarro TT, Cominelli F: Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc Natl Acad Sci USA 103: 8441-8446, 2006
22. Young HA, Tovey MG: TL1A: A mediator of gut inflammation. Proc Natl Acad Sci USA 103: 8303-8304, 2006
23. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992
24. Wang J, Al-Lamki RS, Zhang H, Kirkiles-Smith N, Gaeta ML, Thiru S, Pober JS, Bradley JR: Histamine antagonizes tumor necrosis factor (TNF) signaling by stimulating TNF receptor shedding from the cell surface and Golgi storage pool. J Biol Chem 278: 21751-21760, 2003